Literature DB >> 2124958

Monoclonal process in primary Sjögren's syndrome and cross-reactive idiotype associated with rheumatoid factor.

P D Katsikis1, P Y Youinou, V Galanopoulou, N M Papadopoulos, A G Tzioufas, H M Moutsopoulos.   

Abstract

Monoclonal or oligoclonal B cell products have been described in the sera and urine of patients with primary Sjögren's syndrome (PSS). In addition, monoclonal expansion of plasma cells has been found in the exocrine glands of PSS patients with circulating monoclonal B cell products. The goal of this study was to raise an anti-idiotype to a cryoprecipitable monoclonal IgM kappa rheumatoid factor (RF) from a PSS patient. Using the F(ab')2 fragments of the rabbit IgG anti-idiotype, an idiotype-specific ELISA was developed and sera from 32 patients with PSS (13 with monoclonal IgM kappa), 33 with rheumatoid arthritis, three with rheumatoid arthritis + Sjögren's syndrome (SS), 30 with systemic lupus erythematosus, six with Waldenström's macroglobulinaemia, and 20 healthy controls were tested. The idiotype was primarily found in PSS patients with circulating monoclonal IgM kappa and more often in those who had a ratio of kappa: lambda intracytoplasmically positive plasma cells greater than 3:1 in the lymphocytic infiltrates of minor salivary glands, and systemic manifestations. The idiotype was also found in PSS and rheumatoid arthritis patients without circulating monoclonal cryoglobulins as well as in two of the six patients with Waldenstrom's macroglobulinaemia. Our results suggest that the monoclonal process observed in PSS could involve restricted idiotypic clones that are susceptible to malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124958      PMCID: PMC1535488          DOI: 10.1111/j.1365-2249.1990.tb05481.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Autoantibodies in the sicca syndrome (primary Sjögren's syndrome).

Authors:  K B Elkon; A E Gharavi; G R Hughes; H M Moutsoupoulos
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

2.  Monoclonal antibodies reactive with idiotypic and variable-region specific determinants on human immunoglobulins.

Authors:  J L Greenstein; A Solomon; G N Abraham
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

3.  Immunofixation: application to the identification of "difficult" monoclonal components.

Authors:  E Pascali; A Pezzoli; A Chiarandini
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

4.  Increased risk of lymphoma in sicca syndrome.

Authors:  S S Kassan; T L Thomas; H M Moutsopoulos; R Hoover; R P Kimberly; D R Budman; J Costa; J L Decker; T M Chused
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Antibodies to cellular antigens in Greek patients with autoimmune rheumatic diseases: anti-Ro(SSA) antibody a possible marker of penicillamine-D intolerance.

Authors:  H M Moutsopoulos; H Giotaki; P J Maddison; A C Mavridis; A A Drosos; F N Skopouli
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

7.  Sjögren's syndrome (Sicca syndrome): current issues.

Authors:  H M Moutsopoulos; T M Chused; D L Mann; J H Klippel; A S Fauci; M M Frank; T J Lawley; M I Hamburger
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

8.  IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis.

Authors:  K B Elkon; A E Gharavi; B M Patel; G R Hughes; A Frankel
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

9.  High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome.

Authors:  H M Moutsopoulos; A D Steinberg; A S Fauci; H C Lane; N M Papadopoulos
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  A common idiotope on human rheumatoid factors identified by a hybridoma antibody.

Authors:  D A Carson; S Fong
Journal:  Mol Immunol       Date:  1983-10       Impact factor: 4.407

View more
  3 in total

Review 1.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 2.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 3.  Lymphoproliferation in autoimmunity and Sjögren's syndrome.

Authors:  Michalis Voulgarelis; Haralampos M Moutsopoulos
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.